Stock Information
Celldex Therapeutics Inc (CLDX)
Ticker Symbol: CLDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,063.92 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.8953
Revenue (TTM): $0.02 M
Dividend Yield: N/A%
ROE: -41.67%
Latest News
-
Celldex Therapeutics Files Prospectus To Offer 10,345,000 Shares Of Common Stock
Thu, Apr 2, 2026 5:21 PM
-
Reported Earlier, Celldex Therapeutics Prices $300M Public Offering Of 10,345,000 Common Shares At $29.00 Per Share
Thu, Apr 2, 2026 2:08 AM
-
Celldex Therapeutics shares are trading lower after the company announced an offering.
Wed, Apr 1, 2026 4:32 PM
-
Celldex Therapeutics Commences Common Stock Offering; Terms Undisclosed
Wed, Apr 1, 2026 4:01 PM
Key Financials
Financial data not available
